Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9868760 Protein purification

Patent 9868760 was granted and assigned to Genentech on January, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Genentech
Genentech
0
Date Filed
March 18, 2014
0
Date of Patent
January 16, 2018
0
Patent Applicant
Genentech
Genentech
0
Patent Application Number
14218445
0
Patent Citations Received
‌
US Patent 11992529 Adjuvant treatment of HER2-positive breast cancer
0
‌
US Patent 12128103 Adjuvant treatment of HER2-positive breast cancer
0
‌
US Patent 12110341 Composition comprising antibody that binds to domain II of HER2 and acidic variants thereof
0
‌
US Patent 11654105 Subcutaneous HER2 antibody formulations
0
‌
US Patent 11655305 Treatment of metastatic breast cancer
0
Patent Inventor Names
Jefferson C. Emery
0
Paul J. McDonald
0
Rhona O'Leary
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
9868760
0
Patent Primary Examiner
‌
Maury A Audet
0

Find more entities like US Patent 9868760 Protein purification

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.